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in combination (62% vs 54%, respectively). The safety of 4GCs also 
seems similar to other cephalosporins: in reviews of 3103 patients 
treated with cefpirome and 2032 mated with cefepime, adverse 
events were recorded in 22% and 20.3% of patients, respectively. 
The most commonly-reported AEs are headache, nausea, diarrhea 
and vomiting. It is concluded that 4GCs are suitable agents for the 
treatment of severe n o s o c o d  infections, and show promise for the 
treatment of meningitis and paediatric infections. 
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Objectives: To apply evidenced-based clinical microbiology to the 
management of upper and lower respiratory tract infections. 
Methods: By asking focused questions both practitioners as well as 
microbiologists can enhance the clinical value of microbiological tests 
for respiratory tract mfections. Why is the test being done? What re- 
sults can be expected? Will they be used to start ,  stop, or change ther- 
apy? Is there a simpler (and cheaper) approach? What are the implica- 
tions of not doing the test? What are the pitfaus of empirical therapy? 
Results: Most causes of nonexudative and exudative pharyngi- 
tis (adenovirus and Epstein-Barr virus) are viral. Cultures for group 
A smptococci are imperative if direct antigen tests are negative or 
if susceptibdxty testing is required owing to failures with antibiotics 
other than ,%lactams. Cultures rarely are required for acute otitis me- 
dia or sinusitis; complicated and chronic infections necessitate tym- 
panocentesis or direct aspirates. Cultures are not indicated for acute 
exacerbations of chronic bronchitis. To query pneumonias, sputum 
samples should be screened for quality (presence of neutrophils and 
absence of squamous epithelial cells) unless legionellosis or tuber- 
culosis is suspected. The gram-stained smear may suffice unless 
gram-negative bacilli and purulence are seen or penicillin-resistant 
pneumococci are sought. Cultures without Gram s t a i n s  defy inter- 
pretation. Many “atypical” pneumonias, includmg mycoplasma and 
chlamydia, are not routinely confirmed by laboratory testing. 
Conclusions: Microbiological investigations can be increased in 
value by asking appropriate questions and submitting only relevant 
specimens. 
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The prion, the transmissible agent that causes mad cow disease and 
scrapie, is believed to be PrP*, a misfolded form of a normal host 
protein, PrPc, whch is found mainly in the central nervous system, 
but also in many other organs. PrPc is encoded by a single copy 
gene called plnp. The ‘)rolein only” hypothesis proposes that PrP’ 
propagates by causing conversion of PrPc into PrP’. We generated 
mice devoid of PrPc (“Prnp”” “) mice and found them to be totally 
resistant to scrapie and incapable of propagating prions. Introduction 
of PrP transgenes restored susceptibility to scrapie, paving the way to 
reverse genetics. We have prepared axumals transgenic for PrP genes 
with diverse mutations and determined which part ofthe molecule is 
important for susceptibility to scraspie. We have also introducing PrP 
genes controlled by promotors leading to overexpression in various 
tissues and have determined that expression of PrP in T cells is insuf- 
ficient to allow prion propagation, while expression in splenocytes is 
permissive, suggesting that other components may be required. Re- 
garding practical applications, we expect that cattle or sheep devoid 
of PrP genes should be resistant to scrapie; the knockout technology 
is however not yet available for cattle. 
I S85a I Infectious diseases and migration: risks and 
B. Gushulak. C H  
No abstract available. 
perception for the 21st century 
Trends in nosocomial infections in Europe 
(ESCMID Study Group on Nosocomial 
Infections) 
Is86/ Epidemiology of Nosocomial Infections in 
Europe: Can We Better? 
C. Ruef. University Hospital qfzurich, Zurich, Switzerland 
Nosocomial infections (NI )  are a burden to the health care systems of 
all European countries and often pose sigdicant problem for local 
providers of care. However, not irhequently, patients colonized or 
infected with nosocomial pathogens are transferred between coun- 
tries or regions. Therefore, the way NI are controlled, prevented 
or treated in one country m y  have consequences for the care of 
patients in other countries. 
Improved knowledge of the epidemiology of NI in Europe is 
needed in order to a) anticipate potential problems, i.e. associated 
with transfer of patients who are colonized or infected with muleire- 
sistant organisms; b) monitor the incidence and prevalence of noso- 
comial mfections; c) detect the epidemic spread of relevant pathogens 
(i.e. MRSA, penicillin-resistant pneumococci); d) locally improve the 
practice ofmfection control and infectious diseases by adapting meth- 
ods oflocal practice to procedures which have been shown to be suc- 
cessful in other countries. Sound and uniformly applied epldemiolog- 
ical methods are needed in order to obtain meaningful data on inci- 
dence and prevalence of nosocomial infections in various European 
countries. It wdl be necessary to coordmate national efforts on an in- 
ternauonal level. Such cooperations will likely be fi-uidul and result in 
a better acceptance of hospital epidemiology as a pro-active specialty 
which goes beyond the simple tabulation of infection rates. Such a 
pro-active approach will contribute to the continuous improvement 
